The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 155-161 , January 2003

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

Received 23 June 2002 ,Revised 27 September 2002 ,Accepted 10 October 2002.

References 

  1. Nelson HS. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol. 2000;106:41–45
  2. Franklin W, Lowell FC. Comparison of two dosages of ragweed extract in the treatment of pollenosis. JAMA. 1967;201:915–917
  3. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol. 1993;91:709–722
  4. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, et al.  Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991;88:27–32
  5. Majchel AM, Proud D, Friedhoff L, Creticos PS, Norman PS, Naclerio RM. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992;90:85–91
  6. Creticos PS, Marsh DG, Proud D, Kagey-Sobotka A, Adkinson NF, Friedhoff L, et al.  Responses to ragweed pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989;84:197–205
  7. Alvarez-Cuesta E, Cuesta-Herranz J, Puyana-Ruiz J, Cuesta-Herranz C, Blanco-Quiros A. Monoclonal antibody-standardized cat extract immunotherapy: risk/benefit effects from a double-blind placebo study. 1994;93:556–566
  8. Van Metre TE, Marsh DG, Adkinson NF, Kagey-Sobotka A, Khattignavong A, Norman PS, et al.  Immunotherapy for cat asthma. J Allergy Clin Immunol. 1988;82:1055–1068
  9. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy. 1997;27:860–867
  10. Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow K, et al.  Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol. 1991;87:955–964
  11. Nielsen L, Johnsen CR, Mosbech H, Poulsen LK, Malling H-J. Antihis-tamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol. 1996;97:1207–1213
  12. Bousquet J, Lebel B, Khivert H, Bataille Y, Martinot B, Michel FB. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy. 1987;17:529–536
  13. Lack G, Nelson HS, Amran D, Oshiba A, Jung T, Bradley KL, et al.  Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J Allergy Clin Immunol. 1997;99:530–538
  14. Alam R, Sim TC, Hilsmeier K, Grant JA. Development of a new technique for recovery of cytokines form inflammatory sites in situ. J Immunol Methods. 1992;155:25–29
  15. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med. 1994;149:339–344
  16. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med. 1995;152:927–933
  17. Wang T, Brown MJ. MRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Anal Biochem. 1999;269:198–201
  18. Dreskin S, Dale S, Foster S, Martin D, Buchmeier A, Nelson H. Measurement of mRNA for IL-5 in scrapings of nasal epithelium from patients with allergic rhinitis undergoing nasal allergen challenge. J Immunol Methods. 2002; In press
  19. Spahn JD, Fost DA, Covar R, Martin RJ, Brown EE, Szefler SJ, et al.  Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann Allergy Asthma Immunol. 2001;87:501–505
  20. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames (IA): Iowa State University Press; 1980;
  21. Conover WJ. Practical nonparametrics statistics. New York: Wiley; 1971;
  22. Curran-Everett D. Multiple comparison: philosophies and illustrations. Am J Physiol Regulatory Integrative Comp Physiol. 2000;279:R1–R8
  23. Nish WA, Charlesworth EN, Davis TL, Whisman BA, Valier S, Charlesworth MG, et al.  The effect of immunotherapy on the cutaneous late phase response to antigen. J Allergy Clin Immunol. 1994;93:484–493
  24. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol. 1988;82:439–446
  25. Des Roches A, Paradis L, Knani J, Hejjaoui A, Dhivert H, Chanez P, et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996;51:430–433
  26. Gehlhar K, Schlaak M, Becker W-M, Bufé A. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy. 1999;29:497–506
  27. Nakagawa T, Kozeki H, Katagirir J, Fujita Y, Yamashita N, Miyamoto T, et al.  Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis. Int Arch Allergy Appl Immunol. 1987;82:95–99
  28. Djurup R, Osterballe O. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass levels early in immune therapy. Allergy. 1984;39:433–441
  29. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol. 1997;99:254–260
  30. Majori M, Caminati A, Corradi M, Brianti E, Scarpa S, Pesci A. T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma. Clin Exp Allergy. 2000;30:341–347

☆ Reprint requests: Harold S. Nelson, MD, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206.

PII: S0091-6749(02)91303-5

doi: 10.1067/mai.2003.41

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 155-161 , January 2003

Article Tools

* Image Usage & Resolution